Overview Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis Status: Completed Trial end date: 2015-04-01 Target enrollment: Participant gender: Summary This study is to evaluate the efficacy and safety of M518101 in subjects with plaque psoriasis. Phase: Phase 3 Details Lead Sponsor: Maruho North America Inc.